Censa Pharmaceuticals Overview
- Founded
- 2015
- Status
- Acquired/Merged
- Employees
- 7
- Latest Deal Type
- M&A
- Latest Deal Amount
- $539M
Censa Pharmaceuticals General Information
Description
Developer of bio-medical therapeutics designed to treat (ultra) orphan CNS disorders. The company's therapeutics treat orphan metabolic diseases with earlier stage programs targeting central nervous system diseases, disorders of neurotransmitter degradation and synthesis, enabling patients to recover debilitating diseases.
Contact Information
Website
Ownership Status
Acquired/Merged
(Operating Subsidiary)
(Operating Subsidiary)
Financing Status
Formerly VC-backed
Primary Industry
Biotechnology
Other Industries
Pharmaceuticals
Drug Delivery
Parent Company
Primary Office
- 65 William Street
- Suite 200
- Wellesley, MA 02481
- United States
+1 (781) 000-0000
Censa Pharmaceuticals Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 4. Merger/Acquisition | 29-May-2020 | $539M | 00.000 | 00000 | Completed | Clinical Trials - Phase 3 |
| 3. Merger/Acquisition | 05-Jan-2018 | 0000 | 0000 | Cancelled | Startup | |
| 2. Early Stage VC | 21-Nov-2017 | $1.5M | $3.01M | Completed | Startup | |
| 1. Angel (individual) | 19-Apr-2016 | $1.51M | $1.51M | 000.00 | Completed | Startup |
Censa Pharmaceuticals Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Series A | 000,000 | 00.000000 | 00 | 00 | 00 | 00 | 00 | 0.000 |
Censa Pharmaceuticals Comparisons
Description
Primary
Industry
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last Financing Details
Developer of bio-medical therapeutics designed to treat (ultra) orphan CNS disorders. The company's therapeutics treat o
Biotechnology
Wellesley, MA
7
As of 2018
00.000
0000
0000-00-00
000000&0
00.000
00000000
do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostru
00000000000 0000000
San Rafael, CA
0000
As of 0000
00000
0000
00000
Add Comparison
PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.
Request a free trialCensa Pharmaceuticals Competitors (1)
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| 00000000 000000000 | Formerly PE-Backed | San Rafael, CA | 0000 | 00000 | 0000 | 00000 |
Censa Pharmaceuticals Executive Team (2)
| Name | Title | Board Seat | Contact Info |
|---|---|---|---|
| Johnathan Reis MD | President & Chief Executive Officer | ||
| Christopher Schelling | Founder |
Censa Pharmaceuticals Signals
Growth Rate
0.80%
Weekly
Growth
Growth
Weekly Growth
0.80%, 93rd %ile
-35.5%.
530%
Size Multiple
219x
Median
Size Multiple
219x, 100th %ile
0.00x
0.95x.
413Kx
Key Data Points
Twitter Followers
5.5k
Similarweb Unique Visitors
15.0K
Majestic Referring Domains
314
PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.
Request a free trialCensa Pharmaceuticals Former Investors (2)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|---|---|---|---|---|
| Arkin Holdings | PE/Buyout | Minority | 000 0000 | 000000 0 | |
| InClin | Other | Minority | 000 0000 | 000000 0 |